Intravenous immunoglobulin therapy: Modification of the immunofluorescence pattern in the skin of six patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 39, Issue 4, 1996, Pages 704-705

  Puddu, P ^a   De Pita O ^a   Ruffelli, M ^a   Bellucci, A M ^a   Girardelli, C R ^a   Galeazzi, M ^b   Marcolongo, R ^b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CORTICOSTEROID; FIBRIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIGEN-ANTIBODY COMPLEX; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SKIN;

EID: 0029969187     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390426     Document Type: Article

References (15)

1. Imbach P, Barandum S, D'Apuzzo V, Hirt A, Rossi E, Best M, Baumgartner C, Morell A, Schoni M, Wagner HP: High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228-1231, 1981
2. Pollack S, Cunningham-Rundles C, Smithwick M, Barandum S, Good RA: High dose intravenous gammaglobulin for autoimmune neutropenia. N Engl J Med 309:458-464, 1982
3. Fateh-Moghadam A, Wick M, Besinger U, Guersen RG: High dose intravenous gammaglobulin for myasthenia gravis. Lancet 1:848-849, 1984
4. Roifman CM, Schaeffer FM, Wachsmuth SE: Reversal of chronic polymyositis following intravenous immune serum globulin therapy. JAMA 258:513-515, 1987
5. Schwartz SA: Intravenous immunoglobulin for therapy of autoimmune disorders. J Clin Immunol 112:278-280, 1990
6. Corvetta A, Della Bitta R, Gabrielli A, Spaeth PJ, Danieli G: Use of high-dose intravenous immunoglobulin in systemic lupus erythematosus-associated thrombocytopenia. Clin Exp Rheumatol 7:295-299, 1989
7. Sturfelt G, Mousa F, Jonsson H, Nived O, Thysell H, Wollheim F: Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gamma globulin in a patient with systemic lupus erythematosus. Ann Rheum Dis 49:939-941, 1990
8. Francioni C, Galeazzi M, Fioravanti A, Gelli F, Megale F, Marcolongo R: Long term IV Ig treatment in systemic lupus erythematosus. Clin Exp Rheumatol 12:163-168, 1994
9. Jungi IW, Bricic M, Kuiinert P, Spycher MO, Li F, Nyddegger UE: Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes. Clin Exp Immunol 82:163-169, 1990
10. Delfraissy JF, Tehernia G, Laurian Y, Wallon C, Galanaud P, Dormont J: Suppressor cell function after intravenous gammaglobulin treatment in adult idiopathic thrombocytopenic purpura. Br J Haematol 60:315-322, 1985
11. Rossi F, Dietrich G, Kazatchkine MD: Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses. Immunol Rev 110:135-149, 1989
12. Rossi F, Kazatchkine MD: Anti-idiotypes against autoantibodies in pooled normal human polyspecific immunoglobulins. J Immunol 143:4104-4109, 1989
13. Lin CY, Hsu HC, Chang H: Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gammaglobulin. Nephron 53:303-310, 1989
14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
15. Galeazzi M, Tuzi T, De Pità O, Ruffelli M, Sarti P: Repeat skin biopsies of nonlesional skin in patients with systemic lupus erythematosus (letter). Arthritis Rheum 26:1294-1295, 1983